Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV003389294 | SCV004101311 | likely pathogenic | Dilated cardiomyopathy 1G | 2023-07-21 | criteria provided, single submitter | clinical testing | The TTN c.87077del (p.Pro29026ArgfsTer14) variant causes a shift in the protein reading frame that is predicted to result in premature termination of the protein. Loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay is expected. This variant is located in exon 327 of the meta transcript of titin within the A-band, which is highly expressed in cardiac tissue (PMID: 25589632). In a meta-analysis of TTN truncating variants in dilated cardiomyopathy patients and controls, variants in this region were associated with a significantly increased risk of developing dilated cardiomyopathy (odds ratio 49.8) (PMID: 27869827). This variant is not observed at a significant frequency in version 2.1.1 or version 3.1.2 of the Genome Aggregation Database. Based on the available evidence, the c.87077del (p.Pro29026ArgfsTer14) variant is classified as likely pathogenic for dilated cardiomyopathy. |